0001382963-16-000251.txt : 20161025 0001382963-16-000251.hdr.sgml : 20161025 20161025215349 ACCESSION NUMBER: 0001382963-16-000251 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161025 FILED AS OF DATE: 20161025 DATE AS OF CHANGE: 20161025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 310-203-1000 MAIL ADDRESS: STREET 1: 1880 CENTURY PARK EAST, SUITE 1000 CITY: LOS ANGELES STATE: CA ZIP: 90067 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ritter Andrew J CENTRAL INDEX KEY: 0001631671 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 161951405 MAIL ADDRESS: STREET 1: C/O RITTER PHARMACEUTICALS INC. STREET 2: 1801 CENTURY PARK EAST, SUITE 1820 CITY: LOS ANGELES STATE: CA ZIP: 90096 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-10-25 0001460702 RITTER PHARMACEUTICALS INC RTTR 0001631671 Ritter Andrew J RITTER PHARMACEUTICALS, INC. 1880 CENTURY PARK EAST, #1000 LOS ANGELES CA 90067 1 1 1 0 President Non-qualified Stock Option (Right to Buy) 2.60 2016-10-25 4 A 0 140044 0 A 2026-10-25 Common Stock 140044 140044 D The option vests ratably over 48 months following the public disclosure of top-line data results from the Issuer's Phase 2b/3 clinical trial. /s/Andrew J. Ritter 2016-10-25